Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Whyme16on Mar 07, 2022 8:55am

132 Views

Post# 34489607

What's happening to B Warrants!

Investors bought the warrants based on promisses made by this scam of a company and now it's all going to be worthless!!!! And now we have been waiting for a clarification to HREC for over TWO weeks!! These guys are criminals and fraudsters making deals with their buddies to ensure maximum damage to investors BEFORE handing ownership to Salzman!! Why was there even questions from HREC after MONTHS if not YEARS of delay making the submission?? Bob is PERSONALLY respnsible for this disastor.....SHAME

<< Previous

Bullboard Posts

Next >>

Thesis Gold makes high-grade discovery at Ring Zone